Patients News | pharmaphorum

News

COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality?

England's cancer therapy backlog 'could take more than a dec...

A new report has suggested it could take until 2033 to clear the backlog of cancer treatment in England caused by the pandemic.

News

Coronavirus vaccine: how pharma is picking up the pace

Amnesty says COVID jab producers are causing human rights cr...

Amnesty International has slammed the six pharma companies behind the bulk of COVID-19 vaccine supplies for not agreeing to waive their intellectual property rights and share the technology

News

Study finds 10% of medicines in England are overprescribed

An alarming number of people in England are being prescribed medicines unnecessarily, which could harm their health, according to a UK government review.

News

Pfizer, BioNTech prep low-dose COVID jab filing for kids age...

With positive phase 2/3 results for their COVID-19 vaccine Comirnaty in hand for the five to 11 age group, Pfizer and BioNTech are planning to move swiftly ahead with a filing for emergency

News

Astellas reports fourth death in halted gene therapy trial

There has been a fourth patient fatality in Astellas' clinical trial of its AT132 gene therapy for the rare disease X-linked myotubular myopathy (XLMTM), which has been halted twice due to

News

UK poised to announce booster COVID jabs for over-50s

The UK government is due to announce a large-scale booster vaccine campaign against COVID-19 for all adults aged 50 and over later today, adding to its plan for third doses for people with

England's cancer therapy backlog 'could take more than a dec...

Amnesty says COVID jab producers are causing human rights cr...

Study finds 10% of medicines in England are overprescribed

Pfizer, BioNTech prep low-dose COVID jab filing for kids age...

Astellas reports fourth death in halted gene therapy trial

UK poised to announce booster COVID jabs for over-50s

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks